Skip to main content
. 2013 Feb 14;19(6):936–945. doi: 10.3748/wjg.v19.i6.936

Table 2.

Preexisting diabetes and risk of gastric cancer by subgroup meta-analysis using random effect model

Studies (n) RR (95%CI) I2 % (95%CI)
Overall 27 1.19 (1.08-1.31) 70.7 (56.8-80.2)
Countries
East Asian countries1 10 1.19 (1.02-1.38) 60.1 (20.0-80.1)
Western countries2 17 1.18 (1.03-1.36) 75.6 (61.0-84.8)
Study type
Cohort study 18 1.20 (1.08-1.34) 75.5 (61.2-84.5)
Case control study 9 1.12 (0.87-1.45) 57.9 (11.8-79.9)
Sex
Male 12 1.10 (0.97-1.24) 74.9 (55.7-85.8)
Female 9 1.24 (1.01-1.52) 58.9 (14.1-80.3)
DM criteria
Registration 8 1.21 (1.02-1.44) 83.0 (67.8-91.0)
Measured3 5 1.15 (1.01-1.32) 35.5 (0.0-75.8)
Self report 14 1.13 (0.93-1.39) 65.2 (38.6-80.3)
Interval4
One and more years 15 1.15 (1.02-1.31) 67.5 (44.3-81.0)
Quality (NOS)
High quality (8 and more) 17 1.17 (1.05-1.31) 73.4 (57.0-83.6)
Low quality (7 and less) 10 1.20 (0.97-1.49) 61.2 (22.6-80.5)
Adjustment for risk factor
Smoking5 12 1.17 (1.01-1.34) 52.6 (8.7-75.4)
H. pylori5 2 2.35 (1.24-4.46) 0.0 (UC)
Cancer site
Cardia cancer 2 1.39 (0.72-2.69) 82.3 (UC)
Noncardia cancer 2 1.19 (0.80-1.77) 59.6 (UC)
1

Japan, South Korea;

2

United States, Canada, Europe and Israel;

3

Using fasting blood glucose or HbA1c as criteria;

4

The least cancer-free time of subject according to study design;

5

The subgroup of studies designed to include the risk factor as adjustment variables. RR: Relative risk; UC: Unable to calculate due to low degree of freedom; NOS: Newcastle-Ottawa Quality Assessment Scale; H. pylori: Helicobacter pylori.